ACB Aurora Cannabis, Inc.: Year-over-year net earnings per share growth for the last 12 months

auroramj.com - graphic logo of issuer ACB

Aurora Cannabis is stabilizing its position by shifting focus from retail to the export of medical products. The relative growth in quarterly EPS helps filter out market noise and assess the real financial trend, where the current metric equals 64.50. Outlooks rely on expansion in Australia and Europe alongside cost reductions. The business's moderate cyclicality depends on legalization and consumer demand.

Aurora Cannabis Inc. (ACB) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/16/2026

auroramj.com (ACB) - metric breakdowns and financial figures

Initial company analysis:auroramj.com, ACB
Manufactured product of Aurora Cannabis

This indicator tracks the rate of change in earnings per share (EPS) on a rolling quarterly basis. By analyzing the quarterly EPS trend, investors can assess the actual efficiency of capital generation. Growth in this metric confirms operational resilience and the scalability of the business model. For Aurora Cannabis (ACB), this reflects the financial impact of implementing energy-efficient irrigation and lighting systems. Resource optimization and ESG standards are directly converting into profit growth.

Who Aurora Cannabis competes with

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|Year-over-year net earnings per share growth for the last 12 months Achieve Life Sciences, Inc. ACHV|skyebioscience.com - Year-over-year net earnings per share growth for the last 12 months|Anebulo (ANEB) - Earnings per share growth in annualized terms for the last twelve months|Canndoc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Year-over-year earnings per share growth for the last twelve months|India Globalization Capital - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MIRA Pharma|FLGC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months IMC (IMCC)|ADIL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ARTL (Artelo)|Year-over-year earnings per one share growth for the last 12 months ENSC|Titan Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AKAN|Year-over-year earnings per share growth for the last twelve months Enveric Corp|Earnings per share growth in annualized terms for the last twelve months brightgreen.us BGXX|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)